Gradients Contact Us

The Science

Permanent enhancements in wellbeing.

A permanent increase in hedonic setpoint is scientifically feasible.

01

Hedonic hotspots

Pleasure is produced in cubic-millimeter regions of the brain.

Kent Berridge's lab at the University of Michigan has spent thirty years mapping where pleasure is generated. They identified cubic-millimeter 'hedonic hotspots' in the ventral pallidum and nucleus accumbens where opioid stimulation doubles or triples the pleasure response to taste. Analogous hotspots have since been mapped for several other neurotransmitter classes.

Peciña & Berridge, J. Neuroscience 2005 · Smith & Berridge 2005 · Castro & Berridge 2014

What hasn't been tried

Every published experiment uses acute stimulation to study mechanism. No one has attempted chronic enhancement of these hotspots for sustained hedonic elevation in healthy individuals.

02

Focused ultrasound

Non-invasive drug delivery to targeted brain regions is real.

Focused ultrasound with microbubbles temporarily opens the blood-brain barrier in targeted regions — producing 5–8× increased drug concentration in sonicated tissue, with the barrier closing within hours. Ongoing clinical trials cover Alzheimer's, Parkinson's, ALS, and glioma. Current spatial resolution is 1–5mm; advanced systems now reach 0.3mm.

Rezai et al., NEJM 2024 · Abrahao et al., Nature Communications 2019 · multiple glioma trials 2015–present

What hasn't been tried

Every clinical trial to date targets disease pathology. The delivery system has never been used for psychedelics or any hedonic-enhancing compound. The technology exists; the application is unclaimed.

03

The lateral habenula

The brain's disappointment center can be silenced for 24+ hours.

The lateral habenula is hyperactive in depression — the brain's anti-reward signal, encoding continuous disappointment. Ketamine produces rapid antidepressant effects by blocking burst firing here, and remains trapped in NMDA receptors for up to 24 hours despite a 13-minute plasma half-life. Silencing this region reliably lifts mood.

Yang et al., Nature 2018 · Ma et al., Nature 2023 · Hu Lab, Zhejiang University

What hasn't been tried

No published program has combined lateral habenula suppression with hedonic hotspot activation. The logic is straightforward: reduce the negative floor while raising the positive ceiling. A dual-target approach that has yet to be tested.

04

FAAH and the hedonic set-point

Lifelong hedonic enhancement is biologically stable.

Jo Cameron, a Scottish woman with mutations disabling FAAH — the enzyme that breaks down anandamide, the body's endogenous cannabinoid — scores 0/21 on standard anxiety questionnaires, and has never felt depressed or scared. Her condition persists without tolerance or adaptation across seven decades.

Habib et al., British Journal of Anaesthesia 2019 · Mikaeili et al., Brain 2023

What hasn't been tried

Cameron demonstrates that the hedonic set-point can be shifted upward permanently without tolerance developing. The question is no longer whether it is possible, but how to reach that state deliberately — pharmacologically, genetically, or through targeted stimulation.

05

Deep brain stimulation

Sustained mood elevation, across years, without tolerance.

Continuous DBS of the subcallosal cingulate has held treatment-resistant depression patients in remission for years — response rates remain above 50% at the eight-year mark. Helen Mayberg's lab has been running this since 2005. Mood elevation is maintainable; the circuit does not adapt.

Crowell et al., Am. J. Psychiatry 2019 · Mayberg Lab, 2005–present

What hasn't been tried

Every DBS study targets depression circuitry. None target hedonic circuitry directly — the VP hotspot or nucleus accumbens. The invasive proof of sustained neuromodulation exists; the non-invasive translation is open.

Therapeutics for wellbeing won't discover themselves.

Get in touch